The Effect of Adenosine A2A Receptor Antagonists on Hydroxyl Radical, Dopamine, and Glutamate in the Striatum of Rats with Altered Function of VMAT2

被引:0
|
作者
Krystyna Gołembiowska
Anna Dziubina
机构
[1] Institute of Pharmacology,
[2] Polish Academy of Sciences,undefined
来源
Neurotoxicity Research | 2012年 / 22卷
关键词
Parkinson’s disease; Adenosine A; receptor antagonists; VMAT2 function; Oxidative stress;
D O I
暂无
中图分类号
学科分类号
摘要
It has been shown that a decreased vesicular monoamine transporter (VMAT2) function and the disruption of dopamine (DA) storage is an early contributor to oxidative damage of dopamine neurons in Parkinson’s disease (PD). In our previous study, we demonstrated that adenosine A2A receptor antagonists suppressed oxidative stress in 6-hydroxydopamine-treated rats suggesting that this effect may account for neuroprotective properties of drugs. In the present study, rats were injected with reserpine (10 mg/kg sc) and 18 h later the effect of the adenosine A2A receptor antagonists 8-(3-chlorostyryl)caffeine (CSC) and 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM 241385) on extracellular DA, glutamate and hydroxyl radical formation was studied in the rat striatum using in vivo microdialysis. By disrupting VMAT2 function, reserpine depleted DA stores, and increased glutamate and hydroxyl radical levels in the rat striatum. CSC (1 mg/kg) but not ZM 241385 (3 mg/kg) increased extracellular DA level and production of hydroxyl radical in reserpinised rats. Both antagonists decreased the reserpine-induced increase in extracellular glutamate. l-3,4-Dihydroxyphenylalanine (L-DOPA) (25 mg/kg) significantly enhanced extracellular DA, had no effect on reserpine-induced hydroxyl radical production and decreased extracellular glutamate concentration. CSC but not ZM 241385 given jointly with L-DOPA increased the effect of L-DOPA on extracellular DA and augmented the reserpine-induced hydroxyl radical production. CSC and ZM 241385 did not influence extracellular glutamate level, which was decreased by L-DOPA. It seems that by decreasing the MAO-dependent DA metabolism rate, CSC raised cytosolic DA and by DA autoxidation, it induced hydroxyl radical overproduction. Thus, the methylxanthine A2A receptor antagonists bearing properties of MAO-B inhibitor, like CSC, may cause a risk of oxidative stress resulting from dysfunctional DA storage mechanism in early PD.
引用
收藏
页码:150 / 157
页数:7
相关论文
共 50 条
  • [11] Selective adenosine A2A receptor antagonists
    Ongini, E
    Monopoli, A
    Cacciari, B
    Baraldi, PG
    FARMACO, 2001, 56 (1-2): : 87 - 90
  • [12] Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion
    Peterson, Jayms D.
    Goldberg, Joshua A.
    Surmeier, D. James
    NEUROBIOLOGY OF DISEASE, 2012, 45 (01) : 409 - 416
  • [13] A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity
    Belcastro, Vincenzo
    Tozzi, Alessandro
    Tantucci, Michela
    Costa, Cinzia
    Di Filippo, Massimiliano
    Autuori, Alessia
    Picconi, Barbara
    Siliquini, Sabrina
    Luchetti, Elisa
    Borsini, Franco
    Calabresi, Paolo
    EXPERIMENTAL NEUROLOGY, 2009, 217 (01) : 231 - 234
  • [14] Effect of free radicals on adenosine A2A and dopamine D2 receptors in the striatum of young adult and aged rats
    Alfaro, TM
    Vigia, E
    Oliveira, CR
    Cunha, RA
    NEUROCHEMISTRY INTERNATIONAL, 2004, 45 (05) : 733 - 738
  • [15] Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function
    Fuxe, K
    Ferré, S
    Canals, M
    Torvinen, M
    Terasmaa, A
    Marcellino, D
    Goldberg, SR
    Staines, W
    Jacobsen, KX
    Lluis, C
    Woods, AS
    Agnati, LF
    Franco, R
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2005, 26 (2-3) : 209 - 219
  • [16] Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function
    Kjell Fuxe
    Sergi Ferré
    Meritxell Canals
    Maria Torvinen
    Anton Terasmaa
    Daniel Marcellino
    Steven R. Goldberg
    William Staines
    Kirsten X. Jacobsen
    Carmen Lluis
    Amina s. Woods
    Luigi F. Agnati
    Rafael Franco
    Journal of Molecular Neuroscience, 2005, 26 : 209 - 220
  • [17] Altered dopamine release in VMAT2 mutant mice has little effect on refractive development
    Landis, Erica
    Yang, Victoria
    He, Li
    Lohr, Kelly
    Iuvone, P. Michael
    Pardue, Machelle T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [18] A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases
    Merighi, Stefania
    Borea, Pier A.
    Varani, Katia
    Vincenzi, Fabrizio
    Jacobson, Kenneth A.
    Gessi, Stefania
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (24) : 4138 - 4151
  • [19] Medicinal chemistry of A2A adenosine receptor antagonists
    Caceiari, B
    Pastorin, G
    Spalluto, G
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (04) : 403 - 411
  • [20] Adenosine A2A Receptor Antagonists for Cancer Immunotherapy
    Yu, Fazhi
    Zhu, Chenyu
    Xie, Qiong
    Wang, Yonghui
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (21) : 12196 - 12212